Characterizing Obesity Interventions and Treatment for Children and Youths During 1991-2018

Bach Xuan Tran1,2, Son Nghiem3, Clifford Afoakwah4

  • 1Institute for Preventive Medicine and Public Health, Hanoi Medical University, Hanoi 100000, Vietnam. bach.ipmph@gmail.com.

Insights

Childhood obesity interventions are increasingly focused on multilevel approaches like family and school programs. Research on these treatments is growing, but more support is needed for low-resource settings to combat rising obesity rates.

Area of Science:

  • Public Health
  • Pediatrics
  • Health Policy

Background:

  • Overweight and obesity are global health crises, increasing morbidity and mortality.
  • Current treatments include lifestyle changes, medication, and surgery.
  • Limited understanding exists regarding research trends in childhood obesity interventions.

Purpose of the Study:

  • To analyze the research landscape, topics, and trends of interventions for childhood overweight and obesity.
  • To identify research productivity and workflow in this field from 1991 to 2018.

Main Methods:

  • Bibliometric analysis of 20,925 publications from the Web of Science database (1991-2018).
  • Latent Dirichlet Allocation (LDA) used for topic identification.
  • Dendrogram analysis employed for research discipline categorization.

Main Results:

  • A significant increase in publications on multilevel interventions (family-based, school-based, community-based) was observed.
  • Research output on interventions for children and adolescents with overweight/obesity is disproportionately low in low-resource settings.
  • This contrasts with the rising prevalence of youth overweight and obesity in these regions due to cultural and nutritional shifts.

Conclusions:

  • Multilevel interventions are a growing focus in childhood obesity research.
  • There is an urgent need for increased support from developed nations to address the global rise in childhood overweight and obesity, particularly in underserved regions.
  • Further research and targeted interventions are crucial for mitigating the health and societal burden of pediatric obesity.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
182
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
208
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
143
Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results...
2.0K
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
394